Financing, Equity Capital Markets
ALX Oncology
10/23
|
$63.2 Million
Âé¶¹´«Ã½ served as bookrunner for ALX Oncology Holdings Inc. on a confidentially marketed follow-on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sector
Sub-Sector
Biopharma